BRAF and chronic myelogenous leukemia, BCR-ABL1 positive: Just as pimozide shows enhanced efficacy in CML when combined with BCR/ABL inhibitors, pimozide may be particularly useful in melanoma when combined with BRAF inhibitors [32, 33].